Literature DB >> 12011152

Hereditary non-polyposis colorectal cancer: current risks of colorectal cancer largely overestimated.

J Carayol, M Khlat, J Maccario, C Bonaïti-Pellié.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12011152      PMCID： PMC1735123          DOI： 10.1136/jmg.39.5.335

Source DB:  PubMed          Journal:  J Med Genet        ISSN： 0022-2593            Impact factor:   6.318


× No keyword cloud information.
  18 in total

1.  Estimating penetrance from multiple case families with predisposing mutations: extension of the 'genotype-restricted likelihood' (GRL) method.

Authors:  Bernard Bonaïti; Valérie Bonadona; Hervé Perdry; Nadine Andrieu; Catherine Bonaïti-Pellié
Journal:  Eur J Hum Genet       Date:  2010-10-06       Impact factor: 4.246

Review 2.  Rationale for, and approach to, studying modifiers of risk in persons with a genetic predisposition to colorectal cancer.

Authors:  Mark A Jenkins; Melissa C Southey; Graham G Giles; John L Hopper
Journal:  Curr Oncol Rep       Date:  2007-05       Impact factor: 5.075

3.  PEL: an unbiased method for estimating age-dependent genetic disease risk from pedigree data unselected for family history.

Authors:  F Alarcon; C Bourgain; M Gauthier-Villars; V Planté-Bordeneuve; D Stoppa-Lyonnet; C Bonaïti-Pellié
Journal:  Genet Epidemiol       Date:  2009-07       Impact factor: 2.135

4.  Non-parametric estimation of survival in age-dependent genetic disease and application to the transthyretin-related hereditary amyloidosis.

Authors:  Flora Alarcon; Violaine Planté-Bordeneuve; Malin Olsson; Grégory Nuel
Journal:  PLoS One       Date:  2018-09-25       Impact factor: 3.240

5.  Dependence of colorectal cancer risk on the parent-of-origin of mutations in DNA mismatch repair genes.

Authors:  Christine M van Vliet; James G Dowty; Jane L van Vliet; Letitia Smith; Leeanne J Mead; Finlay A Macrae; D James B St John; Graham G Giles; Melissa C Southey; Mark A Jenkins; Gary M Velan; John L Hopper
Journal:  Hum Mutat       Date:  2011-01-25       Impact factor: 4.878

Review 6.  Clinical description of the Lynch syndrome [hereditary nonpolyposis colorectal cancer (HNPCC)].

Authors:  H F A Vasen
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

7.  Risks of Lynch syndrome cancers for MSH6 mutation carriers.

Authors:  Laura Baglietto; Noralane M Lindor; James G Dowty; Darren M White; Anja Wagner; Encarna B Gomez Garcia; Annette H J T Vriends; Nicola R Cartwright; Rebecca A Barnetson; Susan M Farrington; Albert Tenesa; Heather Hampel; Daniel Buchanan; Sven Arnold; Joanne Young; Michael D Walsh; Jeremy Jass; Finlay Macrae; Yoland Antill; Ingrid M Winship; Graham G Giles; Jack Goldblatt; Susan Parry; Graeme Suthers; Barbara Leggett; Malinda Butz; Melyssa Aronson; Jenny N Poynter; John A Baron; Loic Le Marchand; Robert Haile; Steve Gallinger; John L Hopper; John Potter; Albert de la Chapelle; Hans F Vasen; Malcolm G Dunlop; Stephen N Thibodeau; Mark A Jenkins
Journal:  J Natl Cancer Inst       Date:  2009-12-22       Impact factor: 13.506

8.  Splice site mutations in mismatch repair genes and risk of cancer in the general population.

Authors:  Mette Thomsen; Børge G Nordestgaard; Anne Tybjærg-Hansen; Stig E Bojesen
Journal:  Fam Cancer       Date:  2013-09       Impact factor: 2.375

Review 9.  Current hypotheses on how microsatellite instability leads to enhanced survival of Lynch Syndrome patients.

Authors:  Kristen M Drescher; Poonam Sharma; Henry T Lynch
Journal:  Clin Dev Immunol       Date:  2010-06-10

10.  Thyroid cancer in a patient with a germline MSH2 mutation. Case report and review of the Lynch syndrome expanding tumour spectrum.

Authors:  Rein P Stulp; Johanna C Herkert; Arend Karrenbeld; Bart Mol; Yvonne J Vos; Rolf H Sijmons
Journal:  Hered Cancer Clin Pract       Date:  2008-02-15       Impact factor: 2.857
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.